Vimarsana
Biggest News Aggregation in the World

Hot Line Session News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Hot Line Session. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Hot Line Session Today - Breaking & Trending Today

Don't Miss a Beat: ESC Congress 2023 Preview & SELECT Reaction - Vimarsana News

Don't Miss a Beat: ESC Congress 2023 Preview & SELECT Reaction

In this episode of Don't Miss a Beat, hosts offer a breakdown of 3 trials of note from the upcoming ESC Congress 2023 and provide context around the recent announcement of topline results from the SELECT trial.

Meta-Analysis Strengthens Evidence for SGLT2 Inhibitors in Patients With Heart Failure - Vimarsana News

Meta-Analysis Strengthens Evidence for SGLT2 Inhibitors in Patients With Heart Failure

Prespecified meta-analysis of DELIVER and EMPEROR-Preserved presented in a Hot Line Session at ESC Congress 2022 

Restrictive Oxygenation in Post Cardiac Arrest Patients is Not Harmful - Vimarsana News

Restrictive Oxygenation in Post Cardiac Arrest Patients is Not Harmful

BOX trial presented in a Hot Line Session at ESC Congress 2022 

Trial Finds no Benefit of Raising Blood Pressure Target in Post Cardiac Arrest Patients - Vimarsana News

Trial Finds no Benefit of Raising Blood Pressure Target in Post Cardiac Arrest Patients

BOX trial presented in a Hot Line Session at ESC Congress 2022 

Factor XIa Inhibitor Encouraging in Phase 2 MI, Stroke Studies - Vimarsana News

Factor XIa Inhibitor Encouraging in Phase 2 MI, Stroke Studies

It's all exploratory, but asundexian given with antiplatelets showed safe nuanced potential against poststroke recurrent events and quashed circulating factor XIa after stenting for acute MI.